Cargando…

Non-HLA Genetic Factors and Their Influence on Heart Transplant Outcomes: A Systematic Review

BACKGROUND: Improvement of immunosuppressive therapies and surgical techniques has increased the survival rate after heart transplantation. Nevertheless, a large number of patients still experience complications, such as allograft rejection, vasculopathy, kidney dysfunction, and diabetes in response...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Setten, Jessica, Warmerdam, Evangeline G., Groot, Olivier Q., de Jonge, Nicolaas, Keating, Brendan, Asselbergs, Folkert W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415970/ https://www.ncbi.nlm.nih.gov/pubmed/30882026 http://dx.doi.org/10.1097/TXD.0000000000000859

Ejemplares similares

Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension
por: Hemerich, Daiane, et al.
Publicado: (2018)

LoFTK: a framework for fully automated calculation of predicted Loss-of-Function variants and genes
por: Alasiri, Abdulrahman, et al.
Publicado: (2023)

Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk
por: Tragante, Vinicius, et al.
Publicado: (2016)

Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis
por: Schmidt, Amand, et al.
Publicado: (2023)

Algorithms used in telemonitoring programmes for patients with chronic heart failure: A systematic review
por: Brons, Maaike, et al.
Publicado: (2018)

Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes
por: Ansari, David, et al.
Publicado: (2015)

One year improvement of exercise capacity in patients with mechanical circulatory support as bridge to transplantation
por: Felix, Susanne E.A., et al.
Publicado: (2021)

Improving Genetic Association Studies with a Novel Methodology that Unveils the Hidden Complexity of All-Cause Heart Failure
por: Gregg, John T., et al.
Publicado: (2023)

Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)
por: Fishman, Claire E., et al.
Publicado: (2019)

Heart transplantation for end-stage heart failure combined with Q fever isolated to the heart: a case report
por: van ‘t Veer, Marcel, et al.
Publicado: (2020)

Thirty years of heart transplantation at the University Medical Centre Utrecht
por: Sammani, A., et al.
Publicado: (2017)

Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation
por: Liu, Siqi, et al.
Publicado: (2022)

Progress in genetic association studies of plasma lipids
por: Asselbergs, Folkert W., et al.
Publicado: (2013)

Effect of tissue-grouped regulatory variants associated to type 2 diabetes in related secondary outcomes
por: Hemerich, Daiane, et al.
Publicado: (2023)

Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation
por: Sajulga, Ray, et al.
Publicado: (2022)

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity
por: Schmidt, Amand F., et al.
Publicado: (2023)

The Effect of Genetic HLA Matching on Liver Transplantation Outcome: A Systematic Review and Meta-Analysis
por: Kok, Gautam, et al.
Publicado: (2023)

How HLA diversity is apportioned: influence of selection and relevance to transplantation
por: Maróstica, André Silva, et al.
Publicado: (2022)

Non-HLA Antibodies in Kidney Transplantation: Immunity and Genetic Insights
por: Sorohan, Bogdan Marian, et al.
Publicado: (2022)

Donor-Derived Testicular Germ Cell Cancer in a Heart Transplant Recipient
por: Oerlemans, Marish I.F.J., et al.
Publicado: (2021)

Genetic Variants at Chromosome 9p21 and Risk of First Versus Subsequent Coronary Heart Disease Events: A Systematic Review and Meta-Analysis
por: Patel, Riyaz S., et al.
Publicado: (2014)

Rejection-associated Mitochondrial Impairment After Heart Transplantation
por: Romero, Erick, et al.
Publicado: (2020)

Heart transplantation and anti‐HLA antibodY: myocardial dysfunction and prognosis ‐ HeartLAy study
por: Sciaccaluga, Carlotta, et al.
Publicado: (2023)

Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II
por: Ellison, M., et al.
Publicado: (2023)

Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation
por: Sajulga, Ray, et al.
Publicado: (2023)

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening
por: Sammani, Arjan, et al.
Publicado: (2022)

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations
por: Geneugelijk, Kirsten, et al.
Publicado: (2019)

Influence of renal insufficiency pre‐heart transplantation on malignancy risk post‐heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Exome Array Analysis of Susceptibility to Pneumococcal Meningitis
por: Kloek, Anne T., et al.
Publicado: (2016)

A data mining-based cross-industry process for predicting major bleeding in mechanical circulatory support
por: Felix, Susanne E A, et al.
Publicado: (2021)

Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
por: Numan, Lieke, et al.
Publicado: (2021)

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations
por: Sanchez-Mazas, A, et al.
Publicado: (2012)

Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)

Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation
por: McCurdy, Shannon R., et al.
Publicado: (2015)

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
por: Crnko, Sandra, et al.
Publicado: (2020)

Genetic variation within the HLA class III influences T1D susceptibility conferred by high risk HLA haplotypes
por: Valdes, Ana M, et al.
Publicado: (2010)

High Resolution Systematic Digital Histological Quantification of Cardiac Fibrosis and Adipose Tissue in Phospholamban p.Arg14del Mutation Associated Cardiomyopathy
por: Gho, Johannes M. I. H., et al.
Publicado: (2014)

Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review
por: Meijs, Claartje, et al.
Publicado: (2023)

Influence of Donors’ and Recipients’ HLA Typing on Renal Function Immediately After Kidney Transplantation
por: Rostami, Zohreh, et al.
Publicado: (2013)

Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques
por: van der Laan, Sander W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3tmv63utf1rqold21bc5tpggt4